Challenges in recurring superficial fungal infections: a reappraisal for the twenty-first century

Over the last decade, super cial fungal infection (tinea corporis, tinea cruris, and tinea faciei) has been challenged by a rise in the incidence of Trichophyton mentagrophytes species, poor or variable response to antifungal therapy (clinical cure, no response, and/or aggravation of symptoms a er the initiation of an e ective drug), frequent recurrence despite prolonged antifungal therapy, recurrence of lesion with diverse morphology, and/or lack of correlation between drug resistance and treatment outcome; poor correlation of risk factor (fungal infection of nail and disease in families) to chronic fungal disease, and recurrence was conned to treated tinea sites [1-8].